Newbridge Financial Services Group’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$121K	Hold	9,425	–	–	0.02%	286
2025 Q4	$84.7K	Buy	9,425 +2,975	+46%	+$41K	0.01%	339
2025 Q3	$111K	Buy	6,450 +950	+17%	+$11.7K	0.02%	379
2025 Q2	$51.6K	Buy	+5,500	New	+$45.2K	0.01%	500
2023 Q4	–	Hold	0	–	–	–	1274
2023 Q3	–	Sell	-21	Closed	-$815	–	1374
2023 Q2	$856	Hold	21	–	–	﹤0.01%	1231
2023 Q1	$783	Hold	21	–	–	﹤0.01%	1292
2022 Q4	$733	Hold	21	–	–	﹤0.01%	1327
2022 Q3	$1K	Sell	21 -36	-63%	-$2.23K	﹤0.01%	1316
2022 Q2	$3K	Sell	57 -719	-93%	-$36.5K	﹤0.01%	1117
2022 Q1	$56K	Buy	776 +256	+49%	+$21.7K	0.03%	447
2021 Q4	$61K	Buy	520 +484	+1,344%	+$60.6K	0.03%	411
2021 Q3	$5K	Sell	36 -24	-40%	-$3.63K	﹤0.01%	1015
2021 Q2	$10K	Hold	60	–	–	0.01%	985
2021 Q1	$5K	Buy	+60	New	+$4.03K	﹤0.01%	1033
2020 Q4	–	Hold	0	–	–	–	1149
2020 Q3	–	Hold	0	–	–	–	1049